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Abstract
Background
Panic disorder is associated with high productivity costs. These costs, which should be
included in cost-effectiveness analyses (CEA) from a societal perspective, have a consider-
able impact on cost-effectiveness estimates. However, they are often omitted in published
CEAs. It is therefore uncertain whether choosing a societal perspective changes priority set-
ting in future research as compared to a healthcare perspective.
Objectives
To identify research priorities regarding the cost-effectiveness of an early intervention for
subthreshold panic disorder using value of information (VOI) analysis and to investigate to
what extent priority setting depends on the perspective.
Methods
We calculated the cost-effectiveness of an early intervention for panic disorder from a
healthcare perspective and a societal perspective. We performed a VOI analysis, which esti-
mates the expected value of eliminating the uncertainty surrounding cost-effectiveness esti-
mates, for both perspectives.
Results
From a healthcare perspective the early intervention was more effective at higher costs
compared to usual care (€17,144 per QALY), whereas it was cost-saving from a societal
perspective. Additional research to eliminate parameter uncertainty was valued at €129.7
million from a healthcare perspective and €29.5 million from a societal perspective. Addi-
tional research on the early intervention utility gain was most valuable from a healthcare per-
spective, whereas from a societal perspective additional research would generate little
added value.
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Conclusions
Priority setting for future research differed substantially according to the perspective. Our
study underlines that the health-economic perspective of CEAs on interventions for panic dis-
order must be chosen carefully in order to avoid inappropriate choices in research priorities.
Introduction
The results of model-based cost-effectiveness analyses (CEAs) are surrounded by uncertainty
as the available information about costs and effectiveness of interventions in healthcare is
rarely perfect [1]. This uncertainty makes it difficult to guide policy makers because there is a
risk of reimbursing suboptimal treatment options [2, 3]. The increasing financial pressure on
healthcare systems emphasizes that decision uncertainty should be minimized.
Reimbursement decisions based on CEAs require a willingness-to-pay (WTP) threshold,
which represents the maximum amount society is willing to pay for health gains. In cost-effec-
tiveness research, health gains are preferably expressed in quality adjusted life-years (QALYs)
as QALYs allow for comparison between health conditions due the generic character of this
outcome measure. When a WTP threshold for a QALY is determined, the net monetary bene-
fit (NMB) of the treatment alternatives of interest can be calculated by multiplying the WTP
by the QALYs gained and subtracting the additional costs. The treatment alternative with the
highest expected NMB is the preferred option.
A value of information (VOI) analysis estimates the expected value of eliminating the
uncertainty surrounding cost-effectiveness estimates [1, 4]. This uncertainty can be minimized
by performing additional research. Interventions might not be reimbursed because there is too
much uncertainty about the right choice to be made. In that case, a VOI analysis can assist pol-
icy makers in deciding whether it is worthwhile to invest in additional research that could con-
tribute to the reduction of this uncertainty. VOI also informs which specific model parameters
might benefit the most from additional research [1, 2]. For example, this additional research
can pertain to healthcare costs, productivity costs, or treatment effectiveness.
The costs outside the healthcare sector are substantial among patients with mental disorders
[5–8]. In the Netherlands, these costs are higher than the healthcare costs for panic disorder as
almost 90% of the societal costs is estimated to consist of productivity costs [9]. A CEA per-
formed from a societal perspective includes both healthcare costs and costs outside the health-
care sector. According to guidelines CEAs should be performed from a societal perspective in
most countries [10], including the Netherlands [11], but many of these studies on panic disor-
der are performed from a healthcare perspective [12]. Although one could expect that the cost-
effectiveness of interventions for panic disorder would improve when including costs outside
healthcare, only few studies support this assumption. More important, the role of the societal
perspective in setting future research priorities remains uncertain. Because CEAs from a socie-
tal perspective include additional parameters on costs outside healthcare, the research priori-
ties identified by the VOI from a societal perspective might differ from the research priorities
as identified by the analysis from a healthcare perspective.
In a previously published paper [13], we constructed a health economic model to assess the
cost-effectiveness of adding a cognitive behavioral therapy (CBT) based early intervention for
adults with subthreshold panic disorder (STHPD) to the existing health care (usual care) for
people with panic disorder in the Netherlands. We adopted a societal perspective as the model
included both healthcare costs and productivity costs. When the costs outside healthcare are
less relevant for a decision maker, a VOI analysis applied to a CEA from a societal perspective
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may identify inappropriate research priorities. This applies to panic disorder in particular
because the productivity costs have a substantial impact on cost-effectiveness estimates [13].
To our knowledge, a VOI analysis applied to CEAs of interventions for (subthreshold)
panic disorder has not yet been published. It therefore remains unclear whether additional
research into specific model parameters to reduce uncertainty has additional value, and it also
remains unclear whether these research priorities depend on the perspective that is applied.
This information is valuable because decision makers not only have to decide which treatment
alternative to adopt, but also whether more research regarding the decision is desirable [4].
Moreover, the new Dutch guidelines for health economic evaluations require quantification of
uncertainty by means of VOI analysis [11]. In this study, we therefore aim to identify research
priorities regarding the cost-effectiveness of a CBT-based early intervention for STHPD using
VOI analysis and to investigate to what extent priority setting depends on the perspective.
Methods
Cost-effectiveness model
The VOI analysis was applied to a previously developed model-based CEA. Based on this Mar-
kov model constructed in Microsoft Excel [13], we analyzed the cost-effectiveness of adding a
CBT-based early intervention for adults with STHPD to the existing health care for people
with panic disorder in the Netherlands. In brief, the modelled population was classified into
three health states based on the presence and severity of panic symptoms: panic free, STHPD,
and panic disorder. Death was added as an absorbing health state. Patients with STHPD expe-
rience clinically relevant panic symptoms, but they do not meet the established diagnostic cri-
teria for panic disorder [14]. In the Netherlands, the prevalence of STHPD is comparable to
the prevalence of panic disorder (1.9% versus 2.2%) [15].
We applied a cycle length of one year, meaning that patients remained in the same health
state or switched to a connecting health state after one year. The time horizon of the analysis
was five years. Because the long-term effect of the CBT-based early intervention is unknown
we decided that applying the six months treatment effect to a CEA with a time horizon of>5
years would be inappropriate. In the previous cost-effectiveness study [13], a scenario analysis
with a ten-year time horizon was tested. The results were comparable to the results based on a
time horizon of five years. QALYs and costs of the intervention and usual care scenarios were
the outcome of the model. We expressed monetary outcomes in euros (€) for the 2018 price
level. More information on the model and its structure and underlying assumptions are pub-
lished elsewhere [13]. We assigned distributions to the model parameters in order to include
the uncertainty surrounding them. In line with Briggs (2005) [16], cost parameters were
assigned a gamma distribution, and utility parameters were assigned a beta distribution. A
simulation of 10,000 model iterations was performed by drawing random values for the input
parameters, which were used to estimate the mean incremental cost-effectiveness. The model
parameters, 95% confidence intervals, probabilistic distributions, and sources are reported in
the supporting information (S1 Table). The previously developed model was used as a basis for
the current analyses [13], but several aspects were adjusted. Costs were uprated to a more
recent price level (2018), utility data were assigned a beta distribution, and the early interven-
tion relative risk that was multiplied with the STHPD to panic disorder transition probability
was included in the probabilistic sensitivity analysis (log-normal distribution).
Treatment options
Usual care consists of the currently available care for panic disorder in the Netherlands cover-
ing psychotherapy, pharmacotherapy, or a combination of these therapies [13]. We
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investigated the effect of adding a CBT-based early intervention for STHPD to the usual care
for panic disorder in the Netherlands. The early intervention called ‘Don’t Panic’ is a group-
based course for 6–12 adults covering CBT aspects such cognitive restructuring and in vivo
exposure [17, 18]. The intervention consists of eight weekly sessions guided by a prevention
worker and mental health clinician. More detailed information about the treatment alterna-
tives, adherence rates, and panic disorder intervention coverage rates is published elsewhere
[13].
Cost-effectiveness analysis
In addition to the previously published CEA from a societal perspective [13], we also calculated
the cost-effectiveness from a healthcare perspective by excluding the productivity costs. The
societal perspective often refers to the addition of merely productivity costs, while other non-
healthcare costs could be relevant as well [19]. In this research paper, however, the term socie-
tal perspective refers to the inclusion of healthcare costs and productivity costs. Therefore, the
difference between the analyses from both perspectives solely consists of the inclusion of pro-
ductivity costs. Mean costs and QALYs were estimated for usual care and the CBT-based early
intervention. We applied annual discount rates for both costs (4%) and effects (1.5%) as rec-
ommended by the Dutch health economic guidelines [13, 20]. The incremental cost-effective-
ness ratio (ICER) was calculated by dividing the difference in healthcare and societal costs
between both scenarios by the difference in QALYs. We constructed a cost-effectiveness
acceptability curve, which shows the cost-effectiveness probability of the usual care and early
intervention scenarios for a range of WTP threshold values. The early intervention was
deemed cost-effective when the ICER was lower than the WTP of €20,000 per QALY. The
WTP threshold of €20,000 per QALY is a recommended threshold in the Netherlands for dis-
eases with a relatively low disability weight [21].
VOI analysis
In the VOI analysis, the parameter uncertainty in the model was valued. Our VOI analyses
consist of two parts: the expected value of perfect information (EVPI), and the expected value
of partial perfect information (EVPPI). The EVPI represents the estimated value of eliminating
the uncertainty in the model. More specific, the EVPI places an upper boundary on the costs
of performing additional research to eliminate the uncertainty. It can thus be interpreted as
the maximum of costs society should be willing to pay for additional evidence that eliminates
the current decision uncertainty. Having perfect information regarding the cost-effectiveness
of adding a CBT-based early intervention to usual care for panic disorder would protect
against making suboptimal decisions regarding reimbursement and implementation as the
cost-effectiveness estimate based on the model would be certain. The EVPI informs policy
makers whether it is worthwhile to invest in further research that will contribute to the reduc-
tion of the current decision uncertainty.
In the first step, the NMB for every model iteration of each treatment alternative (the addi-
tional CBT-based early intervention and usual care) was calculated by multiplying the WTP by
the QALYs and subtracting the costs. Thereafter we identified the preferred treatment alterna-
tive, which is the alternative that maximizes the NMB for the given WTP threshold based on
current information in the model. Thereafter, the NMB when having perfect information (the
EVPI) was calculated. Within each simulation run, the individual EVPI was equal to the differ-
ence between the NMB of the optimal treatment alternative based on the current information
and the potential maximum NMB. The individual EVPI thus equals zero when the recom-
mended option by the model under current uncertainty has the highest NMB. The individual
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EVPI was averaged over all 10,000 model runs. This method is illustrated in Table 1 for the
analysis from a healthcare perspective. The same methods were applied to the analyses from a
societal perspective.
The population EVPI was calculated from a healthcare and a societal perspective by multi-
plying the average individual EVPI values by the number of STHPD patients in the Nether-
lands who receive the early intervention in the model (n = 198,896). The population EVPI
values from a healthcare perspective and a societal perspective were plotted against a range of
different WTP thresholds, resulting in a population EVPI curve.
Although the population EVPI provides insight into the NMB gained when having perfect infor-
mation, it remains unclear which parameters in the model are associated with the greatest uncer-
tainty. If the uncertainty in the current analysis mainly results from the healthcare costs parameters,
it might not be worthwhile to further investigate the parameters on treatment effectiveness.
To identify for which parameters future research is worthwhile for both perspectives, we
calculated the EVPPI. The EVPPI is calculated as the difference between the expected NMB of
a decision made with perfect information on a group of parameters and the expected NMB
with current information on that group of parameters. In order to calculate the EVPPI, we per-
formed the model simulations (inner loop) for a fixed randomly drawn value for the parame-
ter(s) of interest given a WTP threshold of €20,000 per QALY. Subsequently, new fixed values
of the same parameters were drawn and the simulation was performed again (outer loop). In
line with Mohseninejad et al. [6], the number of inner loops was set at 1,000 and the number
of outer loops at 100. The simulations were repeated to check for stability of the results. We
calculated the EVPPI for the following model parameters or groups of parameters: interven-
tion costs, health-state utilities, utility gain after receiving the early intervention, healthcare
costs, the early intervention relative risk that was multiplied with the STHPD to panic disorder
transition probability, and the productivity costs (societal perspective only).
Results
Cost-effectiveness
Estimates of the QALYs and costs per treatment alternative are shown in Table 2. S1 Fig shows
a scatterplot including the incremental QALYs and costs for the analyses from both
Table 1. Calculating the individual expected value of perfect information (EVPI), example for the analysis from a healthcare perspective.
NMBa
Model runs CBT-based early intervention Usual care Maximum NMB Net benefit gained when having perfect information
1 63,193 65,163 65,163 65,163–63,193 = 1,970
2 56,206 56,904 56,904 56,904–56,206 = 698
3 62,997 61,630 62,997 62,997–62,997 = 0
4 63,466 62,504 63,466 63,466–63,466 = 0
5 62,230 61,703 62,230 62,230–62,230 = 0
. . . . . . . . . . . . . . .
10,000 59,159 59,770 59,770 59,770–59,159 = 611
Meanb 60,831 60,643 61,483 61,483–60,831 = 652c
EVPI: expected value of perfect information, NMB: net monetary benefit.
a NMB was calculated by multiplying QALYs by the WTP threshold of €20,000 per QALY and subtracting costs. The early intervention resulted in the highest overall
NMB for both perspectives.
b The mean of all 10,000 model iterations.
c The individual EVPI (€652) was calculated as the difference between the expected NMB with perfect information and the expected NMB with current information.
https://doi.org/10.1371/journal.pone.0205876.t001
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perspectives resulting from the 10,000 model iterations. From a healthcare perspective, the
ICER of the early intervention versus usual care resulted in €17,144 per QALY gained. The
results from societal perspective showed that the intervention was cost-saving, with an ICER
of €-16,023 per QALY gained. Fig 1 shows the cost-effectiveness acceptability curves, which
shows the cost-effectiveness probability of both treatment options for a range of different
WTP thresholds. Given a WTP threshold of €20,000 per QALY, the estimated cost-
Table 2. Estimates of discounted costs and QALYs per patient and incremental costs and QALYs.
Mean QALYs (95% CI) Mean healthcare costs (95% CI) Mean productivity costs (95% CI)
Additional CBT-based early intervention 3.44 (3.19–3.68) €8,034 (4,941–11,952) €50,912 (35,143–70,055)
Usual care 3.28 (3.08–3.47) €4,934 (2,904–7,481) €58,004 (42,469–75,931)
Incremental 0.16 (0.02–0.32) €3,100 (1,002–5,871) -€7,092 (-18,469–2,997)
CBT: cognitive behavioral therapy, CI: confidence interval, QALYs: quality adjusted life-years
https://doi.org/10.1371/journal.pone.0205876.t002
Fig 1. Cost-effectiveness acceptability curve of the additional CBT-based early intervention and usual care.
https://doi.org/10.1371/journal.pone.0205876.g001
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effectiveness probability for the early intervention was 61% from a healthcare perspective and
93% from a societal perspective.
VOI analysis
As an example, Table 1 presents the generated NMBs for both treatment options for six model
runs of the CEA from a healthcare perspective. The early intervention had the highest NMB
value for the CEAs from both perspectives, and therefore the early intervention was the pre-
ferred treatment option. Therefore, no benefits were gained for model runs that identified the
early intervention as the treatment option with the highest NMB. The individual EVPI values
were €652 from a healthcare perspective and €148 from a societal perspective. Multiplying
these values with the target population (n = 198,896) resulted in population EVPIs of €129.7
million from a healthcare perspective and €29.5 million from a societal perspective given a
WTP threshold of €20,000 per QALY. Reducing all parameter uncertainty was thus valued at a
total of €129.7 and €29.5 million, respectively.
Fig 2 presents the estimated population EVPI values from both healthcare and societal per-
spectives over a range of WTP values. The population EVPI from a healthcare perspective
showed a maximum of €141.2 million at a WTP of €18,900 per QALY. At this threshold, deci-
sion uncertainty was the highest. The probability that the additional early intervention was
cost-effective increased for larger WTP thresholds, and therefore the EVPI decreased. Because
Fig 2. The population expected value of perfect information (EVPI) for different willingness-to-pay thresholds.
https://doi.org/10.1371/journal.pone.0205876.g002
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the early intervention was expected to be more effective at lower costs from a societal perspec-
tive, the cost-effectiveness probability further increased for larger WTP thresholds. As decision
certainty increased with WTP, the societal EVPI declined.
The uncertainty of subsets of parameters was valued in the EVPPI given a WTP threshold
of €20,000 per QALY (Fig 3). Because the model parameters interact within the model struc-
ture and because not all parameters are considered, the EVPPIs do not sum up to the overall
EVPIs for each perspective [22, 23]. When the CEA is performed from a healthcare perspec-
tive, the early intervention utility gain parameter contributed to most of the uncertainty (73%
of total EVPI), followed by the intervention cost parameters and the health-state utility param-
eters (51% and 20% of total EVPI). The population EVPPIs for these groups of parameters
equaled €94.9 million, €66.7 million, and €25.8 million, respectively. The EVPPIs for the
healthcare cost parameters and the relative risk for the early intervention equaled €21.4 and
€15.7 million. When the cost-effectiveness analysis was performed from a societal perspective,
the EVPPI of the early intervention relative risk parameter equaled €10.2 million. The EVPPIs
for the remaining (groups of) parameters were equal to zero, including the productivity costs,
which indicates that there was no expected value of further research into these parameters.
Discussion
In this study, we aimed to identify research priorities regarding the cost-effectiveness of a
CBT-based early intervention for STHPD using VOI analysis and to investigate to what extent
priority setting depends on the perspective. The decision uncertainty was relatively high when
Fig 3. Expected value of partial perfect information (EVPPI) from both perspectives given a willingness-to-pay threshold of €20,000 per QALY.
https://doi.org/10.1371/journal.pone.0205876.g003
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a healthcare perspective was applied, and eliminating uncertainty was valued at a total of
€129.7 million for a WTP of €20,000 per QALY. The decision uncertainty in our model is
comparable to other cost-effectiveness analyses on psychological interventions in mental
healthcare that applied a healthcare perspective [6, 24]. Additional research on the early inter-
vention utility gain in the model was most valuable from a healthcare perspective. However,
when a societal perspective was applied, the decision uncertainty was minimal and additional
research was expected to have little added value. The EVPI for specific (groups of) parameters
(EVPPI) equaled zero from a societal perspective, except for the early intervention relative risk
parameters. These results indicate that additional research on the healthcare costs, productivity
costs, health-state utilities, early intervention utility gain, and intervention costs considered in
the model would not generate value from a societal perspective.
Our results indicate that the cost-effectiveness estimates and the potential value of addi-
tional research substantially differed when we applied a societal perspective instead of a health-
care perspective. From a societal perspective, additional research would generate little
additional value whereas further research from a healthcare perspective could be considered
worthwhile, especially for the utility gain associated with the early intervention. When health-
care policy makers decide to invest in a CBT-based early intervention for STHPD at a WTP of
€20,000 per QALY, the cost-effectiveness probability that the early intervention is cost-effec-
tive is only 61%. Because this decision uncertainty is relatively high, reducing decision uncer-
tainty would be beneficial for healthcare policy makers. Investing in additional research on the
early intervention utility gain, intervention costs, and health-state utilities in order to reduce
uncertainty could be considered. For employers or others investors for whom the societal per-
spective is relevant, on the other hand, additional research is not likely to be worthwhile as
additional information within the probabilistic sensitivity analysis would not generate addi-
tional value. It is unlikely that investing in additional research on the parameters included in
the VOI will yield extra information regarding the decision from a societal perspective, which
emphasizes the importance of identifying the relevant perspective for the CEA.
In a comparable VOI analysis on a minimal intervention for depression [6], however, addi-
tional research on the costs outside healthcare generated most value from a societal perspec-
tive. Additional research on this model parameter was considered worthwhile. The same WTP
threshold of €20,000 per QALY was applied [6]. A possible explanation for this difference
could be that in our study the intervention was more cost-saving. Consequently, the uncer-
tainty surrounding the non-healthcare costs parameters might have been less influential as
even for lower thresholds the early intervention was cost-saving. Another VOI analysis in the
field of mental health was applied to an intervention on reducing juvenile delinquency [3]. In
that study, the healthcare costs and intervention costs were relatively uncertain, which is com-
parable to our findings from a healthcare perspective. However, comparing results between
different CEAs and VOI analyses is difficult because of the different model structures, input
parameters, and parameters included in the probabilistic sensitivity analysis and EVPPI.
To our knowledge, our study is the first to apply a VOI analysis to cost-effectiveness
research in the field of (subthreshold) panic disorder. A strength of the application of this anal-
ysis is that it values the uncertainty surrounding the cost-effectiveness estimate, which pro-
vides valuable input for policy decisions regarding investments in future research. There are
also some limitations that require discussion. The VOI analysis in this article estimates the
value of eliminating the parameter uncertainty of the presented model, but two other relevant
sources of uncertainty may have influenced the results which were not captured by VOI analy-
sis: structural and methodological uncertainty [25, 26].
Structural uncertainty is likely to be present in our model. For example, we did not apply
different health-state transition rates for individuals who received any treatment for panic
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disorder due to a lack of available information [13]. Instead, the effectiveness of interventions
was reflected in utility gains. It was assumed that patients who received interventions for panic
disorder had the same chance of remission as patients who did not receive an intervention
[13]. Therefore, the effect of the interventions for panic disorder might have been underesti-
mated. We did not calculate the EVPPI for the health state transition parameters since they
were fixed. We consider this as a limitation, because in a comparable VOI study the health-
state transition rates were the most uncertain [3].
The second source of uncertainty is methodological uncertainty, which relates to the analyt-
ical methods used in the model. One aspect related to this uncertainty is the WTP threshold,
which requires attention given its importance for our study. We applied a WTP of €20,000 per
QALY in our study, which we used for the CEAs and VOI of both health economic perspec-
tives. However, a WTP of €20,000 is mostly used for a healthcare setting [6, 27]. Although the
application of different WTP thresholds for CEAs from a healthcare and a societal perspective
is uncommon in published CEAs, it has been mentioned that using a different WTP according
to perspective might be more appropriate [28, 29]. A reason is that from a societal perspective
threshold values should reflect the consumption of health from a societal perspective, while
from a healthcare perspective WTP thresholds would reflect the marginal value of health pro-
vided for by a publicly financed health care system, which are not always the same. As it is
likely that a societal WTP would be larger than the healthcare WTP and because the addition
of productivity costs in a CEA improves cost-effectiveness in most cases we can expect that the
cost-effectiveness would always be more favorable from a societal perspective when an inter-
vention is more effective than the comparator. We could therefore expect that the value of
additional research as identified by VOI from a societal perspective would decrease as the
intervention already has less uncertainty about the most cost-effective option compared to the
healthcare perspective.
The effect of the early intervention that was applied in the model was largely based on one
trial (n = 216) [18]. Although our results indicate that from a societal perspective the value of
additional research would be minimal compared to the healthcare perspective, it remains
uncertain to what extent the results of this trial can be extrapolated to the general population
in the Netherlands. Therefore, additional research investigating the effect of the early interven-
tion is still desirable. VOI is limited to the uncertainty surrounding parameter estimates, but
neither the quality nor the interpretation of the parameters is considered. These types of
uncertainty are not reflected in the EVP(P)I. Assuming that the choices in our model are a
good approximation of reality, additional research is expected to have little additional value
from a societal perspective.
In order to incorporate the treatment effect of the early intervention in the transition proba-
bilities, we applied a log-normal distributed relative risk to the STHPD to panic disorder tran-
sition. A limitation of our study is that the remaining transition parameters in the model were
fixed. However, as the intervention’s cost-effectiveness is primarily the result of the interven-
tion’s reduction in the STHPD to panic disorder transition, the uncertainty in the other transi-
tion rates can be considered of second-order importance.
Although VOI analysis quantifies the value of uncertainty, in general and for specific model
parameters, its practical application remains difficult [30]. The EVPI is estimated on the
assumption that only cost-effectiveness outcomes guide decision making. However, additional
decision makers’ constraints such as the maximum budget impact and health equity are usu-
ally not taken into account [30]. For future research and policy decisions on early interven-
tions for panic disorder, it is therefore important that such considerations are identified.
In conclusion, our results showed that research priorities regarding an early intervention
for STHPD differed according to the health-economic perspective applied to the CEA. The
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VOI analysis indicated that additional research to eliminate uncertainty surrounding the cost-
effectiveness estimate is worthwhile when the CEA is performed from a healthcare perspective,
but less so when a societal perspective was applied. When the probability that an intervention
is more effective as well as cost-saving is high, the value of additional research is likely to be
minimal. Because performing a VOI analysis is recommended in the new Dutch guidelines for
economic evaluations in healthcare [11], a conscious consideration of the health-economic
perspective used for CEAs on interventions for panic disorder is therefore important. Our
study underlines that the health-economic perspective of CEAs on interventions for panic dis-
order must be chosen carefully in order to avoid inappropriate choices in research priorities.
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